BREAKING DOWN SILOS. CONNECTING EXPERTISE. ACCELERATING PATIENT IMPACT.
Precision Medicine East, formerly NextGen Omics, Spatial & Data US, brings together the scientific disciplines, technologies and decision-makers advancing drug development, clinical research, diagnostics and patient care.
, ,
Introducing
Precision Medicine East
Precision medicine has changed, and so has our event in Boston.
Omics, spatial biology and AI have changed what’s possible in precision medicine. But turning that data into better decisions takes biomarker, pathology, data and clinical teams working together, and too often they still meet apart.
That’s why, from 2027, NextGen Omics, Spatial & Data US is now Precision Medicine East. In Boston, 15 years of omics and spatial community is joined by biomarkers, companion diagnostics and computational pathology, in four interconnected programs. The science you came for remains. What’s new is the East Coast’s precision medicine ecosystem, in one room.
Watch our CEO and Founder, Cerlin Roberts, explain the thinking behind the change.
What is Precision Medicine East?
Precision Medicine East is a two-day conference in Boston for the people advancing precision medicine: R&D leaders, clinicians, researchers, data scientists, investors and technology providers. Organized by Oxford Global, it runs four interconnected programs in biomarkers and companion diagnostics, computational pathology, multi-omics, and AI and data, with spatial biology across the agenda. Small-group formats, pre-arranged meetings and dedicated zones for AI and startups turn the science into decisions.
Explore the Precision Medicine East Programs
Why attend Precision Medicine East
- Explore the full precision medicine ecosystem: four interconnected programs in Biomarkers & CDx; Computational Pathology, AI & Precision Diagnostics; Multi-Omics Development & Applications; and AI, Data & Analysis, with spatial biology across the agenda.
- Meet the people carrying precision medicine forward: R&D and clinical development leaders, clinicians, researchers, data scientists, investors and technology providers from pharma, biotech, academia and healthcare.
- Work in formats built for exchange: Collaboration Hubs, panel discussions, closed-door sessions and roundtables, designed for discussion, not just presentation.
- See what’s ready to use: live demonstrations in the AI & Data Zone, and the next wave of science in the Startup Zone.
- Make the meetings that matter: pre-booked one-on-one meetings in the Networking Lounge, scheduled around the sessions so you never miss the content.
About
NextGen Omics, Spatial & Data US is now Precision Medicine East. Discover what’s changed.
Onsite experiences at Precision Medicine East
Start-up Zone
A dedicated space for early-stage precision medicine companies to exhibit, pitch and meet investors and pharma partners, all in two days. Eligible start-ups receive a full conference pass, a 10-minute presentation slot and exhibition space to show their technology to the teams who would use it.
AI & Data Zone
Partnering Program
Exhibition & Networking

The Road to Precision Medicine East
Between the events, the conversation carries on online. R&D Spotlights and CEO Thought Leadership sessions run all year, each a stop on the Road to Precision Medicine East.
Precision Medicine East: Frequently Asked Questions
When and where is Precision Medicine East?
March 23–24, 2027, at the Sheraton Boston Hotel in Boston, Massachusetts.
Is Precision Medicine East the same event as NextGen Omics, Spatial & Data US?
Who should attend Precision Medicine East?
What programs run at Precision Medicine East?
Can I meet specific people at Precision Medicine East?
Have a peek into the dynamic panels, engaging roundtables, and hands-on workshops happening in Boston - right now!
Spatial Multi-Omics For Target-To-Disease Linkage In Inflammatory Diseases
MARINA BLECK, Principal Scientist, Boehringer Ingelheim
Marina discussed the use of multi omics for faster Faster Target-to- Disease Link (T2DL) with increased confidence and how they can leverage Spatial Biology to enhance the ability to derive insight from human disease tissues. Finally the Importance of FFPE Tissue Quality for Spatial Biology was discussed with the use of QC scoring to determine which FFPE tissue gives the best spatial transcriptomics results.
Spatial Biology As A Discovery Pathway
EMRE ARSLAN, Takeda
Emre Arslan from Takeda gave a talk about the use of Spatial Biology as a discovery pathway. First of all providing an update on the current landscape for spatial technologies then analysing how spatial technologies can be used in clinical trial design - such as the ability to identify previously unknown cell types, interactions and microenvironments and providing an ideal foundation for training better AI models.
JASMINE PLUMMER, Director, St Jude Children's Research Hosptial
Jasmine Plummer's day 2 keynote focused on Single cell into spatial and beyond. "The reason we are in this room is because it’s cutting edge" which is why the single cell and spatial field growing exponentially.
Future directions for the technology include Low throughput, clinical trials, other organisms, more tissue types, epigenomics
JUN WANG, Associate Professor, Multiplex Biotechnology Laboratory, Department of Biomedical Engineering, Stony Brook University
"Simpler but more powerful than flow and imaging cytometry"
MIST Technology provides100 times more information than flow cytometry and currently the highest multiplexity is up to 500 markers/ cell.
Panel Application Of Single Cell Omics In Clinical Monitoring
PRIYA CHOCKALINGAM, Vice President, Head of Clinical BioAnalytics & Translational Sciences, Beam Therapeutics
Priya's talk focused on Genome Editing Technologies for Gene & Cell Therapy and how cell & gene therapies require a specialized regulatory approach compared to other modalities. Appropriate assessments should therefore be put in place in both nonclinical and clinical stages to address safety concerns.
Various methods to assess off-target editing effects have evolved in the last decade. However, limitations remain in balancing accuracy vs sensitivity of these new techniques.
The direct assessment of off-target effects in vivo and in patients is particularly challenging.
Novel single-cell technologies enable quantitation/co-occurrence of on-/off-target editing through patient time-course of treatment
Comparative Insights In Single Cell RNA-seq & Advances In Large-Scale Multimodal Profiling
ZORA MODRUSAN, Senior Director NGS, Genentech
Zora focused on both key insights and future directions of single cell RNA-Seq. scRNA-seq technologies were evaluated and the differences in performance across various metrics such as sensitivity, throughput and cost were compared across different systems.
The Overloading And unpacKing (OAK) method provides a reliable solution for large-scale molecular profiling that incorporates multiple data modalities.
Moving forward they will continue to evaluate the latest scRNA-seq kits to understand differences and guide optimal performance. Zora would also like to enhance OAK's capabilities by integrating additional modalities and applying the platform to a wide range of biological systems.
Key Event Highlights
An unmissable journey awaits you: from celebrated keynote speakers and insightful private roundtables, to the Young Scientist Awards. Discover the moments that will transform your NextGen Omics, Spatial & Data US experience.
Become a driving force in accelerating the next generation of multi-omics-based treatments. NextGen Omics & Spatial Biology US offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, & academic experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, & collaborate with the community shaping the future of genomic medicine today.
Interested in Sponsoring NextGen Biomed?
Become a driving force in accelerating the next generation of biologics and immunotherapy medicines to patients. NextGen Biomed offers a unique platform to enhance your brand visibility and connect with thousands of pharma, biotech, and R&D experts. Our branded event opportunities, immersive experiences, and content services enable you to engage, educate, and collaborate with the community shaping the future of biomedicine today.
Our Esteemed Sponsors for NextGen Omics & Spatial Biology US 2025
Platinum Sponsors
Gold Sponsors
Silver Sponsors
Bronze Sponsors
Network & Programme Sponsors




